| 
Citations
 | 
   web
Zevin, B. (1990). Hepatitis C : from head to toe. In HIV and Hepatitis C Co-infection Workshop. San Francisco Department of Public Health, Tom Waddell Health Center.
Toggle visibility
Uchtenhagen, A. (2003). Risk reduction programmes and policy : objectives, activities, evidence. In Hungarian Civil Liberties Union Conference (29). Budapest: Institut für Suchtforschung (ISF).
Toggle visibility
McDonald, D. (2000). Thinking about drugs policy : some core concepts that might underpin the next stage of Australia's National Drug Strategy. In Families and Friends for Drug Law Reform meeting (13). Canberra: David McDonald.
Toggle visibility
Edlin, B. R. (2002). Injection drug use and hepatitis C. In NIH Consensus Development Conference on Management of Hepatitis C: 2002 (31). Bethesda: Brian R. Edlin.
Toggle visibility
Fromberg, E. (1995). The ideologies behind harm reduction. In 6th International Conference on the Reduction of Drug Related Harm (6). Florence: Erik Fromberg.
Toggle visibility
Hermann, H. (1995). Répercutions des “Gassenzimmer” de Bâle-Ville sur les consommateurs de stupéfiants. In Premier colloque international toxicomanies, hépatites et sida (6). Cannes: Hannes Hermann.
Toggle visibility
Larrey, D. (2003). Effets secondaires du traitement anti-viral dans l'hépatite C. In Sixième colloque international toxicomanies, hépatites, sida. Aix-en-Provence: Dominique Larrey.
Toggle visibility
Moirand, R. (2003). Principes de traitement de l'hépatite C chez le patient addictif. In Sixième colloque international toxicomanies, hépatites, sida (21). Aix-en-Provence: Romain Moirand.
Toggle visibility
various. (1994). Drogenforschungssymposium in Zürich : Referate, Teilnehmerliste. In Drogenforschungssymposium. Zürich.
Toggle visibility
Lavoyer-Bünzli, J. (1997). Projekt : Terminologie illegale Drogen : BAGVertrag Nr. 316.97.6032 : erstes Terminologisches Treffen : zeitlicher und inhaltlicher Rahmen. In erstes Terminologisches Treffen (79). ETchanger.
Toggle visibility